Risk of audiologic side effects with teprotumumab treatment for thyroid eye disease: propensity matched analysis.

چکیده

Patients with thyroid eye disease (TED) taking teprotumumab have reported audiologic symptoms as a side effect; however, limited real world data and large sample sizes have been utilized to evaluate this relationship. A retrospective cohort study was created in TriNetX to identify patients with TED…

متن کامل چکیده در سایت ناشر در دسترس است.

موضوعات مرتبط

• بیماری چشمی تیروئید